Terms And Conditions
  1. Home
  2. Terms And Conditions
Pharmaxis Limited – Pipeline Creates Multip...
By ACE Investors / 13 May 2022
Read More
BWX Limited: Focus on Expanding product Offer...
By ACE Investors / 11 May 2022
Read More
Nova Eye Medical Limited – Comprehensive Po...
By ACE Investors / 10 May 2022
Read More
Paradigm Biopharmaceuticals Ltd (ASX: PAR): U...
By ACE Investors / 05 May 2022
Read More
Resmed Inc. (ASX: RMD): Investments in R&D an...
By ACE Investors / 04 May 2022
Read More
Ramsay Health Care Limited(ASX: RHC): Well Po...
By ACE Investors / 03 May 2022
Read More
Medifast Inc: Scalable Coach-Based Approach T...
By ACE Investors / 28 Apr 2022
Read More
Antisense Therapeutics Limited: ATL1102 Clear...
By ACE Investors / 26 Apr 2022
Read More
Universal Biosensors Inc. – Focused on Deve...
By ACE Investors / 22 Apr 2022
Read More
Lumos Diagnostics Holdings Limited: Possesses...
By ACE Investors / 19 Apr 2022
Read More
Teladoc Health, Inc: Continuous Meaningful Gr...
By ACE Investors / 14 Apr 2022
Read More
Telix Pharmaceuticals Limited (ASX: TLX): App...
By ACE Investors / 07 Apr 2022
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors